Search Results

Femasys Inc. today announced that it has activated enrollment for its pivotal FemBloc® trial at University of California, Davis (“UC Davis”) Medical Center in Sacramento, California.

Caris Life Sciences®, the leading next-generation TechBio company and precision medicine pioneer that is actively developing and delivering innovative solutions to revolutionize healthcare and improve the human condition, announced that UC Davis Comprehensive Cancer Center has joined the Caris Precision Oncology Alliance™.

Probo Medical (“Probo”), a leading global provider of medical imaging equipment, parts, repair and service, announced the acquisition of Davis Medical Electronics, Inc. (“Davis Medical”).

Protagonist Therapeutics, Inc. today announced it has earned a $10 million milestone payment following the dosing of the third patient in ANTHEM-UC, a Phase 2b trial to evaluate the safety and effectiveness of JNJ-2113 compared with placebo in participants with moderately to severely active ulcerative colitis.

Agilent Technologies Inc., a global leader in life sciences, diagnostics, and applied chemical markets, and the University of California San Diego, one of the top-ranked public research universities in the world, announced an innovative scientific collaboration to establish the Agilent Center of Excellence in Cellular Intelligence.

UC Davis, a leading university in molecular imaging that collaborated with United Imaging to develop the world’s first total-body PET/CT scanner, ‘uEXPLORER®,’ recently presented their research on COVID-19 at the 2022 Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting.